Protective effects of ethanolic extract of zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats

Basic and Clinical Pharmacology and Toxicology

Volumn 104, Issue 5, 2009, Pages 366-373

  Nammi, Srinivas ^a   Sreemantula, Satyanarayana ^b   Roufogalis, Basil D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ANDHRA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CHOLESTEROL; FATTY ACID; GINGER EXTRACT; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; ROSIGLITAZONE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIPID DIET; MALE; METABOLIC SYNDROME X; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTECTION; RAT; RHIZOME; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIETARY FATS; ETHANOL; GINGER; INSULIN; LIPIDS; MALE; METABOLIC SYNDROME X; PLANT EXTRACTS; RATS; RATS, WISTAR;

RATTUS; ZINGIBER OFFICINALE; ZINGIBERACEAE;

EID: 64549145497     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00362.x     Document Type: Article

References (48)

1. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 2006 23 : 469 80.
2. Bergman RN, Kim SP, Catalano KJ, Hsu IR, Chiu JD, Kabir M et al. Why visceral fat is bad: mechanisms of the metabolic syndrome. Obesity 2006 14 : 16S 19S.
3. Procopiou M, Philippe J. The metabolic syndrome and type 2 diabetes: epidemiological figures and country specificities. Cerebrovasc Dis 2005 20 : 2 8.
4. Aude YW, Mego P, Mehta JL. Metabolic syndrome: dietary interventions. Curr Opin Cardiol 2004 19 : 473 9.
5. Bray GA, Bellanger T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine 2006 29 : 109 17.
6. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006 444 : 840 6.
7. Lender D, Sysko SK. The metabolic syndrome and cardiometabolic risk: scope of the problem and current standard of care. Pharmacotherapy 2006 26 : 3S 12S.
8. Moller DE. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 2001 414 : 821 7.
9. Afzal M, Al-Haddi D, Menon M, Pesek M, Dharmi MSI. Ginger: an ethnomedical, chemical and pharmacological review. Drug Metab Drug Interact 2001 18 : 159 90.
10. Chrubasik S, Pittler MH, Roufogalis BD. Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles. Phytomedicine 2005 12 : 684 701.
11. Govindarajan V. Ginger-chemistry technology and quality evaluation: Part-1. Crit Rev Food Sci Nutr 1982 17 : 1 96.
12. Govindarajan V. Ginger-chemistry technology and quality evaluation: Part-2. Crit Rev Food Sci Nutr 1982 17 : 189 258.
13. Connell D, Sutherland M. A re-examination of gingerol, shogaol and zingerone, the pungent principles of ginger (Zingiber officinale Roscoe). Aust J Chem 1969 22 : 1033 43.
14. Bhandari U, Sharma JN, Zafar R. The protective action of ethanolic ginger extract in cholesterol-fed rabbits. J Ethnopharmacol 1998 61 : 167 71.
15. Verma SK, Singh M, Jain P, Bordia A. Protective effect of ginger, Zingiber officinale Rosc on experimental atherosclerosis in rabbits. Ind J Exp Biol 2004 42 : 736 8.
16. Bhandari U, Kanojia R, Pillai KK. Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic rats. J Ethnopharmacol 2005 97 : 227 30.
17. Fuhrman B, Rosenblat M, Hayek T, Coleman R, Aviram M. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. J Nutr 2000 130 : 1124 31.
18. Thomson M, Al-Qattan KK, Al-Sawan SM, Alnaqeeb MA, Khan I, Ali M. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins Leukot Essent Fatty Acids 2002 67 : 475 8.
19. Akhani SP, Viswarkarma SL, Goyal RK. Antidiabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats. J Pharm Pharmacol 2004 56 : 101 5.
20. Sivakumar V, Sivakumar S. Effect of indigenous herbal compound preparation 'Trikatu' on the lipid profiles of atherogenic diet and standard diet fed Rattus norvegicus. Phytother Res 2004 18 : 976 81.
21. Ahmed RS, Sharma SB. Biochemical studies on combined effects of garlic (Allium sativum Linn) and ginger (Zingiber officinale Rosc) in albino rats. Ind J Exp Biol 1997 35 : 841 3.
22. Sharma M, Shukla S. Hypoglycemic effect of ginger. J Res Ind Yoga Homeop 1977 12 : 127 30.
23. Mascolo N, Jain R, Jain SC, Capasso F. Ethnopharmacologic investigation of ginger (Zingiber officinale). J Ethnopharmacol 1989 27 : 129 40.
24. Ojewole JAO. Analgesic, anti-inflammatory and hypoglycemic effects of ethanol extract of Zingiber officinale (Roscoe) Rhizomes (Zingiberaceae) in mice and rats. Phytother Res 2006 20 : 764 72.
25. Kar A, Choudary BK, Bandyopadhyay NG. Comparative evaluation of hypoglycemic activity of some Indian medicinal plants in alloxan diabetic rats. J Ethnopharmacol 2003 84 : 105 8.
26. Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr 2006 96 : 660 6.
27. Weidner MS, Sigwart K. The safety of ginger extract in the rat. J Ethnopharmacol 2000 73 : 513 20.
28. Singhal PC, Joshi LD. Glycaemic and cholesterolemic role of ginger and till. J Sci Res Plants Med 1983 4 : 32 4.
29. Goyal RK, Kadnur S. Beneficial effects of Zingiber officinale on goldthioglucose induced obesity. Fitoterapia 2006 77 : 160 3.
30. Han L, Gong X, Kawano S, Saito M, Kimura Y, Okuda H. Antiobesity actions of Zingiber officinale Roscoe. Yakugaku Zasshi 2005 125 : 213 7.
31. Maehata E, Yaho M, Shiba T, Yamakado M, Inoue M, Suzuki S. Insulin resistance index (HOMA-R) method. Nippon Rinsho 2002 60 : 341 50.
32. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 : 499 502.
33. Riccardi G, Giacco R, Rivellese AA. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 2004 23 : 447 56.
34. Fujimoto WY. The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus. Am J Med 2000 108 : 9S 14S.
35. Edelman SV. Type II diabetes mellitus. Adv Intern Med 1998 43 : 449 500.
36. Fernandez ML. The metabolic syndrome. Nutr Rev 2007 65 : S30 4.
37. Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Schömerich J et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol 2006 36 : 485 501.
38. Buettner R, Schömerich J, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity 2007 15 : 798 808.
39. Bordia A, Verma SK, Srivastava KC. Effect of ginger (Zingiber officinale Rosc) and fenugreek (Trigonella foenum graecum L) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1997 56 : 379 84.
40. Isa Y, Miyakawa Y, Yanagisawa M, Goto T, Kang MS, Kawada T et al. 6-Shogaol and 6-gingerol, the pungent of ginger, inhibit TNF-α mediated down regulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Biochem BiophysRes Commun 2008 373 : 429 34.
41. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 2006 580 : 2917 21.
42. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001 7 : 941 6.
43. Neimeijer-Kanters SDJM, Banga JD, Erkelens DW. Lipid lowering therapy in diabetes mellitus. Neth JMed 2001 58 : S14 S19.
44. Tan KC. Management of dyslipidemia in the metabolic syndrome. Cardiovasc Hematol Disord Targets 2007 7 : 99 108.
45. Jones PJ. Regulation of cholesterol biosynthesis by diet in humans. Am J Clin Nutr 1997 66 : 438 46.
46. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986 232 : 34 47.
47. Srinivasan K, Sambaiah K. The effect of spices on cholesterol-7α- hydroxylase activity and on serum and hepatic cholesterol levels in the rat. Int J Vit Nutr Res 1991 61 : 364 9.
48. Tanabe M, Chen YD, Saito KI, Kano Y. Cholesterol biosynthesis inhibitory component from Zingiber officinale Roscoe. Chem Pharm Bull 1993 41 : 710 3.